SPC275
Lorlatíníb eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
19.8.2019Application published:
15.9.2019Grant published:
15.6.2022
Max expiry date:
7.5.2034Medicine name:
LorviquaMedicine for children:
No
Timeline
Today
19.8.2019Application
15.9.2019Publication
15.6.2022Registration
7.5.2034Expires
Marketing license
IS authorization number:
EU/1/19/1355/001; EU/19/1355/002Date:
12.6.2019
Foreign authorization number:
EU/1/19/1355Date:
6.5.2019
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2822953